Aachen, Germany – September 28, 2026 -- Grünenthal and DKSH Business Unit Healthcare have signed a new commercialisation agreement to bring four pain medicines, Qutenza, Vimovo, Palexia and Zomig, to eight Asia-Pacific markets: Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam.